SciELO - Scientific Electronic Library Online

 
vol.46 número3Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientesAnálisis de la certificación en el marco de especialización farmacéutica a nivel internacional índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Farmacia Hospitalaria

versão On-line ISSN 2171-8695versão impressa ISSN 1130-6343

Resumo

SULAIMAN, Helmi; ROBERTS, Jason A  e  ABDUL–AZIZ, Mohd H. Pharmacokinetics and pharmacodynamics of beta-lactam antibiotics in critically ill patients. Farm Hosp. [online]. 2022, vol.46, n.3, pp.182-190.  Epub 25-Jul-2022. ISSN 2171-8695.  https://dx.doi.org/10.7399/fh.13170.

Optimal antibiotic therapy for critically ill patients can be complicated by the altered physiology associated with critical illness. Antibiotic pharmacokinetics and exposures can be altered driven by the underlying critical illness and medical interventions that critically ill patients receive in the intensive care unit. Furthermore, pathogens that are usually isolated in the intensive care unit are commonly less susceptible and “resistant” to common antibiotics. Indeed, antibiotic dosing that does not consider these unique differences will likely fail leading to poor clinical outcomes and the emergence of antibiotic resistance in the intensive care unit. The aims of this narrative review were to describe the pharmacokinetics of beta-lactam antibiotics in critically ill patients, to highlight pharmacokinetic/pharmacodynamic targets for both non-critically ill and critically ill patients, and to discuss important strategies that can be undertaken to optimize beta-lactam antibiotic dosing for critically ill patients in the intensive care unit.

Palavras-chave : Antibiotics; Beta-lactamics; Criticaly ill patient; Clinical pharmacokinetics.

        · resumo em Espanhol     · texto em Inglês | Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )